Free Trial

OrthoPediatrics Corp. (NASDAQ:KIDS) Short Interest Update

OrthoPediatrics logo with Medical background

OrthoPediatrics Corp. (NASDAQ:KIDS - Get Free Report) saw a significant decrease in short interest in January. As of January 31st, there was short interest totalling 826,300 shares, a decrease of 9.7% from the January 15th total of 914,900 shares. Based on an average daily volume of 277,800 shares, the short-interest ratio is currently 3.0 days. Approximately 5.1% of the shares of the stock are short sold.

OrthoPediatrics Trading Down 0.2 %

NASDAQ KIDS traded down $0.05 during trading hours on Thursday, hitting $24.33. The company's stock had a trading volume of 282,105 shares, compared to its average volume of 308,529. The stock has a fifty day moving average of $24.22 and a 200 day moving average of $26.18. The company has a quick ratio of 3.68, a current ratio of 7.17 and a debt-to-equity ratio of 0.19. The firm has a market capitalization of $589.32 million, a P/E ratio of -19.78 and a beta of 1.14. OrthoPediatrics has a twelve month low of $21.02 and a twelve month high of $35.99.

Analyst Ratings Changes

KIDS has been the topic of several analyst reports. Truist Financial cut their price objective on shares of OrthoPediatrics from $28.00 to $25.00 and set a "hold" rating on the stock in a report on Wednesday, December 18th. Needham & Company LLC restated a "buy" rating and issued a $42.00 price objective on shares of OrthoPediatrics in a report on Tuesday, January 14th.

Check Out Our Latest Analysis on OrthoPediatrics

Institutional Investors Weigh In On OrthoPediatrics

Hedge funds have recently bought and sold shares of the company. Quarry LP acquired a new stake in OrthoPediatrics in the third quarter worth $25,000. International Assets Investment Management LLC raised its holdings in OrthoPediatrics by 2,610.8% in the third quarter. International Assets Investment Management LLC now owns 1,003 shares of the company's stock worth $27,000 after purchasing an additional 966 shares during the period. R Squared Ltd acquired a new stake in OrthoPediatrics in the fourth quarter worth $48,000. KLP Kapitalforvaltning AS acquired a new stake in OrthoPediatrics in the fourth quarter worth $79,000. Finally, BNP Paribas Financial Markets increased its position in shares of OrthoPediatrics by 125.1% during the third quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company's stock worth $94,000 after acquiring an additional 1,929 shares in the last quarter. 69.05% of the stock is currently owned by institutional investors and hedge funds.

About OrthoPediatrics

(Get Free Report)

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.

Read More

Should You Invest $1,000 in OrthoPediatrics Right Now?

Before you consider OrthoPediatrics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and OrthoPediatrics wasn't on the list.

While OrthoPediatrics currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock

Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock

Is Marjorie Taylor Greene the next Nancy Pelosi when it comes to stock trading? After being appointed to the DOGE Committee, MTG made a significant Tesla stock purchase—raising questions about congres

Related Videos

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Small Caps, Financials & Bitcoin Lead the Rising Bull Market: Chris Rowe’s Top Picks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines